Dinalbuphine sebacate

From WikiMD's WELLNESSPEDIA

Dinalbuphine sebacate is a narcotic analgesic that is used in the treatment of pain. It is a derivative of buprenorphine, which is a semi-synthetic opioid. Dinalbuphine sebacate is a long-acting formulation, which means it can provide pain relief for a longer period of time compared to other analgesics.

Etymology[edit]

The term "Dinalbuphine sebacate" is derived from its parent drug, buprenorphine. The prefix "Di-" indicates that two molecules of buprenorphine are involved, while "sebacate" refers to the sebacic acid used in the formulation.

Pharmacology[edit]

Dinalbuphine sebacate works by binding to the mu-opioid receptor in the brain, which is responsible for the perception of pain. By binding to this receptor, it can effectively block the transmission of pain signals, providing relief to the patient.

Clinical Use[edit]

Dinalbuphine sebacate is used in the treatment of moderate to severe pain. It is particularly useful in cases where the pain is chronic and requires long-term management. Due to its long-acting formulation, it can provide consistent pain relief over a longer period of time, reducing the need for frequent dosing.

Side Effects[edit]

Like all opioids, dinalbuphine sebacate can cause a range of side effects. These can include nausea, vomiting, constipation, and drowsiness. In some cases, it can also cause respiratory depression, which is a serious condition where breathing becomes dangerously slow.

Related Terms[edit]

Dinalbuphine_sebacate[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.